Your browser doesn't support javascript.
loading
Impact of COVID-19 therapy on hyperglycemia.
Parise, Rachel; Deruiter, Jack; Ren, Jun; Govindarajulu, Manoj; Ramesh, Sindhu; Nadar, Rishi M; Moore, Timothy; Dhanasekaran, Muralikrishnan.
Afiliação
  • Parise R; Department of Drug Discovery and Development, 15460Auburn University Harrison School of Pharmacy, Auburn, AL, USA.
  • Deruiter J; Department of Drug Discovery and Development, 15460Auburn University Harrison School of Pharmacy, Auburn, AL, USA.
  • Ren J; Department of Cardiology, 92323Zhongshan Hospital Fudan University, Shanghai, China.
  • Govindarajulu M; Department of Laboratory Medicine and Pathology, 7284University of Washington, Seattle, WA, USA.
  • Ramesh S; Department of Drug Discovery and Development, 15460Auburn University Harrison School of Pharmacy, Auburn, AL, USA.
  • Nadar RM; Department of Drug Discovery and Development, 15460Auburn University Harrison School of Pharmacy, Auburn, AL, USA.
  • Moore T; Department of Drug Discovery and Development, 15460Auburn University Harrison School of Pharmacy, Auburn, AL, USA.
  • Dhanasekaran M; Department of Drug Discovery and Development, 15460Auburn University Harrison School of Pharmacy, Auburn, AL, USA.
Diab Vasc Dis Res ; 19(3): 14791641221095091, 2022.
Article em En | MEDLINE | ID: mdl-35695412
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / COVID-19 / Hiperglicemia Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Diab Vasc Dis Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / COVID-19 / Hiperglicemia Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Diab Vasc Dis Res Ano de publicação: 2022 Tipo de documento: Article